Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-19

FDA Approved: STEGLATRO — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved STEGLATRO (ertugliflozin) in its original application for adults with type 2 diabetes mellitus to improve glycemic control, including as monotherap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • STEGLATRO (ertugliflozin)

Snippet

ORIG AP for STEGLATRO (ERTUGLIFLOZIN)